Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-01-03 @ 9:01 PM
Study NCT ID:
NCT00214604
Status:
COMPLETED
Last Update Posted:
2010-11-19
First Post:
2005-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Type III Dysbetalipoproteinemia
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hyperlipoproteinemia Type III | View |
Keywords: